<DOC>
	<DOCNO>NCT00086112</DOCNO>
	<brief_summary>The purpose trial determine effectiveness risperidone adjunctive treatment patient GAD demonstrate less-than-optimal response current anxiolytic treatment .</brief_summary>
	<brief_title>Study Comparing Risperidone v Placebo add-on Therapy Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding Standard Therapy .</brief_title>
	<detailed_description>Many patient Generalized Anxiety Disorder ( GAD ) benefit show partial benefit current psychotropic therapy . This trial conduct purpose determine effectiveness risperidone adjunctive treatment patient GAD demonstrate less-than-optimal response current anxiolytic treatment ( either allow antidepressant , benzodiazepine , buspirone , combination ) . Patients randomized ( patient assign different treatment base chance ) either risperidone placebo 4 - 6 week double-blind ( neither patient physician know whether drug placebo take , dosage ) treatment . Patients randomize risperidone continue current anxiolytic treatment ( treatment anxiety ) receive risperidone 0.25 mg per day first 3 day , 0.5 mg per day day 4 14 , 1 mg per day day 15 28 trial . If clinically indicate , day 29 , dose could increase 2 mg per day rest trial ( 4 6 additional week ) . At dose level , risperidone take mouth single daily dose . Patients ask question every one two week , depend phase trial , determine efficacy ( effectiveness ) safety . The study hypothesis risperidone effective adjunct standard psychotropic treatment symptom Generalized Anxiety Disorder placebo , measure composite four trouble symptom identify baseline . Risperidone 0.25 mg per day first 3 day , 0.5 mg per day day 4 14 , 1 mg per day day 15 28 trial . If clinically indicate , day 29 , dose could increase 2 mg per day rest trial ( 4 6 additional week ) . At dose level , risperidone take mouth single daily dose .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Healthy basis physical exam Treatment one allow antidepressant and/or anxiety medication least past 8 week Judgement clinician patient show suboptimal response treatment Current diagnosis Generalized Anxiety Disorder Maintained stable , therapeutic dose ( ) allow medication ( ) least past four week Presence serious medical illness Active use cocaine heroin History suicide attempt past 12 month Changes antidepressant/antianxiety regimen ( medication dose ) within four week precede study baseline ( Day 1 ) History clozapine use</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Anxiety</keyword>
	<keyword>antipsychotic</keyword>
</DOC>